CANCER-LINKED GENE AS TARGET FOR CHEMOTHERAPY

Details for Australian Patent Application No. 2003229294 (hide)

Owner AVALON PHARMACEUTICALS

Inventors EBNER, Reinhard; HORRIGAN, Stephen, K.

Pub. Number AU-A-2003229294

PCT Number PCT/US03/15314

PCT Pub. Number WO2003/097803

Priority 60/380,612 15.05.02 US

Filing date 15 May 2003

Wipo publication date 2 December 2003

Event Publications

14 August 2003 Complete Application Filed

  Priority application(s): 60/380,612 15.05.02 US

29 January 2004 Application Open to Public Inspection

  Published as AU-A-2003229294

3 February 2005 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003229295-CARBON COATED BATTERY ELECTRODES

2003229293-CANCER-LINKED GENE AS TARGET FOR CHEMOTHERAPY